A new study has shown that two drugs - lecanemab and donanemab - could help patients stay independent by approximately 10–13 ...
The reelection of Donald Trump was, in many ways, a correction. A correction for how the media and government have conducted ...
Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
Minnesota wouldn’t be the first to create a position to manage dementia care in the state. Freeman estimates around 30 ...